| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Mar―25 |
Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines - where do we stand? |
Mohammad Mahdi Aliasin, Niloufar Yazdanpanah, Nima Rezaei |
| 2 |
[GO] |
2022―Mar―08 |
Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia? |
Maria Lima, Athina-Maria Aloizou, Vasileios Siokas, Christos Bakirtzis, Ioannis Liampas, Zisis Tsouris, et al. (+3) Dimitrios P. Bogdanos, Stavros J. Baloyannis, Efthimios Dardiotis |
| 3 |
[GO] |
2022―Feb―10 |
Acute cerebrovascular events in severe and nonsevere COVID-19 patients: a systematic review and meta-analysis |
Carolina Quintanilla-Sánchez, Alejandro Salcido-Montenegro, José Gerardo González-González, René Rodríguez-Gutiérrez |
| 4 |
[GO] |
2021―Sep―18 |
Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies |
Raha Zamani, Rozhina Pouremamali, Nima Rezaei |
| 5 |
[GO] |
2021―Aug―13 |
The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses |
Colin Day, Carson Studders, Kim Arklie, Asees Kaur, Kyra Teetzen, Rebecca Kirsch, et al. (+4) Laila Abelseth, Ian Fraser, Emily Abelseth, Stephanie M. Willerth |
| 6 |
[GO] |
2021―Jul―05 |
Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1 |
Kiarash Saleki, Mohammad Banazadeh, Niloufar Sadat Miri, Abbas Azadmehr |
| 7 |
[GO] |
2021―Jun―04 |
The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review |
Masoomeh Dadkhah, Sahand Talei, Donya Doostkamel, Soheila Molaei, Nima Rezaei |
| 8 |
[GO] |
2021―Feb―14 |
Overview of COVID-19 and neurological complications |
Nasrin Hosseini, Shabnam Nadjafi, Behnaz Ashtary |
| 9 |
[GO] |
2021―Feb―14 |
COVID-19 and stroke: from the cases to the causes |
Giovanni Frisullo, Irene Scala, Simone Bellavia, Aldobrando Broccolini, Valerio Brunetti, Roberta Morosetti, et al. (+2) Giacomo Della Marca, Paolo Calabresi |
| 10 |
[GO] |
2021―Feb―13 |
Mitigating the impact of coronavirus disease 2019 on emergency stroke care: an original study and meta-analysis |
Jian Wang, Ye Hong, Mengmeng Ma, Muke Zhou, Jian Guo, Ning Chen, et al. (+8) Jinghuan Fang, Wanping Liu, Yang Zhang, Lizhang Chen, Nanya Hao, Yi Wang, Dong Zhou, Li He |
| 11 |
[GO] |
2021―Feb―05 |
Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences |
Dian Eurike Septyaningtrias, Rina Susilowati |
| 12 |
[GO] |
2021―Jan―23 |
COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis |
Saber Soltani, Alireza Tabibzadeh, Armin Zakeri, Amir Mohammad Zakeri, Tayebeh Latifi, Mahdi Shabani, et al. (+7) Amir Pouremamali, Yousef Erfani, Iraj Pakzad, Pooneh Malekifar, Reza Valizadeh, Milad Zandi, Reza Pakzad |
| 13 |
[GO] |
2021―Jan―14 |
COVID-19 infection and stroke risk |
Shaghayegh Sadeghmousavi, Nima Rezaei |
| 14 |
[GO] |
2020―Dec―22 |
CNS implications of COVID-19: a comprehensive review |
Priyanka Nagu, Arun Parashar, Tapan Behl, Vineet Mehta |
| 15 |
[GO] |
2020―Nov―17 |
COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy? |
Milena de Barros Viana, Bárbara dos Anjos Rosário, Maria de Fátima Santana de Nazaré, Débora Estadella, Daniel Araki Ribeiro, Glauce Socorro de Barros Viana |
| 16 |
[GO] |
2020―Aug―18 |
Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19) |
Niloufar Yazdanpanah, Amene Saghazadeh, Nima Rezaei |
| 17 |
[GO] |
2020―May―28 |
The involvement of the central nervous system in patients with COVID-19 |
Kiarash Saleki, Mohammad Banazadeh, Amene Saghazadeh, Nima Rezaei |
